-
Dispensary Corner 17 Feb 26
Tuesday | Feb 17 2026SCIENTISTS have debunked the long-held idea that humans have five senses – sight, sound, smell, taste and touch – suggesting there could be as many as 33.
-
PD for Tue 17 Feb 2026
Tuesday | Feb 17 2026RACGP opted out of chance to have say on EACPP, PSA calls for branch committee nominations, concerning AMR increase in Australia, and more
-
Doctors demand evidence of scope safety
Monday | Feb 16 2026THE Royal Australian College GPs (RACGP) has called for “guardrails to protect patient safety”, following a Western Australia Government announcement that a further 40 pharmacists will start prescriber training this month as part of the Enhanced Access Community Pharmacy Pilot (PD 08 Aug 2025), adding to the 50 already training.
-
TWC launches women’s health focus
Monday | Feb 16 2026TERRYWHITE Chemmart (TWC) today launched a new national women’s health focus, positioning its community pharmacists as a trusted frontline destination for women’s health care.
-
CF drug PBS-listed
Monday | Feb 16 2026FOLLOWING its approval by the TGA last year (PD 24 Nov 2025), cystic fibrosis (CF) drug Alyftrek (vanzacaftor/tezacaftor/deutivacaftor, Vertex) is now PBS-listed.
-
Neffy available
Monday | Feb 16 2026CSL Seqirus has announced that neffy adrenaline (epinephrine) nasal spray is now available.
-
Guild to launch first pharmacy owner census since 2012
Monday | Feb 16 2026THE Pharmacy Guild of Australia is set to launch its first member census for more than a decade, giving every pharmacy owner the opportunity to share the realities of their business, team and future ambitions.
-
Dispensary Corner 16 Feb 26
Monday | Feb 16 2026SEAWEED – it may be slippery, slimy, and not exactly an appealing addition to one’s diet, but it does happen to also be a pretty powerful superfood.
-
PD for Mon 16 Feb 2026
Monday | Feb 16 2026GPs demand evidence that pharmacist expanded scope is safe, TWC launches women’s health focus, Guild member census coming in March, and more
-
World-first clinical guide for MDMA
Friday | Feb 13 2026A NEW Australian Clinical Practice Guideline for the Appropriate Use of methylenedioxymethamphetamine-assisted psychotherapy (MDMA-AP) for post-traumatic stress disorder (PTSD) has been approved by the National Health and Medical Research Council (NHMRC).
PARTNER SITES
to top